Bisacodyl
Bisacodyl
CLINICAL USE
Laxative
DOSE IN NORMAL RENAL FUNCTION
Oral: 5–10 mg at nightRectal: 10 mg in the morningBowel evacuation:
10 to 20     : mg orally at night followed by 10 mg as suppositories the next morning PHARMACOKINETICS
Molecular weight                           :361.4 %Protein binding                           :Negligible %Excreted unchanged in urine     : 30 Volume of distribution (L/kg)       :half-life – normal/ESRD (hrs)      : DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : Dose as in normal renal function 10 to 20     : Dose as in normal renal function <10           : Dose as in normal renal function DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Unknown dialysability. Dose as in normal renal function HD                     :Unknown dialysability. Dose as in normal renal functionHDF/high flux   :Unknown dialysability. Dose as in normal renal functionCAV/VVHD      :Unknown dialysability. Dose as in normal renal function IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsNone known ADMINISTRATION
Reconstition
– Route
Oral, rectal Rate of Administration
–Comments
– OTHER INFORMATION
Absorption is <5% orally or rectally Rapidly converted in the gut (by intestinal and bacterial enzymes) to its active, but non-absorbed, desacetyl metabolite
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home